🔴 Damora Therapeutics is trading 5% down — catalyst remains unclear

Damora Therapeutics is trading 5.27% lower at $19.56, with no clear company-specific or broad-market catalyst identified for the October 5 decline.

• The latest identified company release was an October 2 announcement of employee inducement grants.
• Supplied market context showed mixed, relatively modest index moves, with no broad decline exceeding 0.5% to explain the drop.